Statistically significant ( p < 0.0001) differences in the distribution of patient EQ-5D-3L utility indices were observed across ECOG-PS subgroups, with an apparent trend for worsening EQ-5D-3L score with declining ECOG-PS (from a mean of 0.84 for patients with an ECOG-PS of 0 to a mean of 0.29 for those with an ECOG-PS of 3 or 4; Fig. 1 ).
← all excerpts
The humanistic burden of advanced non-small cell lung cancer (NSCLC) in Europe: a real-world survey linking patient clinical factors to patient and caregiver burden.
1
—
—